P5057-5G Display Image

Paromomycin sulfate salt, powder, BioReagent, suitable for cell culture, >=98%

Code: P5057-5G D2-231

Application

Paromomycin sulfate salt has been used as a:reference compound in antileishmanial activity RNA-binding ligand and interacts with aptamer. This interaction prevent...


read more

Your Price
£239.00 5G
£286.80 inc. VAT

Application

Paromomycin sulfate salt has been used as a:reference compound in antileishmanial activity RNA-binding ligand and interacts with aptamer. This interaction prevents the binding (and cutting) of dicer to RNA duplex.Recommended for use in cell culture applications at 100mg/L.

Paromomycin sulfate salt has been used as a positive control to compare the purine analog antiviral 2′,3′-dideoxyinosine (ddI).

Biochem/physiol Actions

Paromomycin inhibits the initiation and elongation steps of protein synthesis by binding to 16S ribosomal RNA. Paramomycin binds to the A site, which causes defective polypeptide chains to be produced and leads to cell death.

Paromomycinpossesses antileishmanial and antibacterial activities. It is used to cure visceral leishmaniasis (VL) and cutaneous leishmaniasis (CL). This aminocyclitol glycoside is active against gram-negative and gram-positive bacteria. It is also active against E. histolytica, D. fragilis and several cestodes, like Taenia saginata, Taenia solium etc.

General description

Paromomycin or aminosidine, an aminoglycoside belongs to the class of aminoglycosides. This nonabsorbableantibiotic is found at high level in the lumen of the colon.

Chemical structure: aminoglycoside

Other Notes

Keep container tightly closed in a dry and well-ventilated place.Keep in a dry place

1g,5g

antibiotic activity spectrumGram-positive bacteria, Gram-negative bacteria
formpowder
InChI keyOYJABWUHUYVDMJ-UDXJMMFXSA-N
InChI1S/C23H45N5O14.CH4/c24-2-7-13(32)15(34)10(27)21(37-7)41-19-9(4-30)39-23(17(19)36)42-20-12(31)5(25)1-6(26)18(20)40-22-11(28)16(35)14(33)8(3-29)38-22;/h5-23,29-36H,1-4,24-28H2;1H4/t5-,6+,7+,8-,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+;/m1./s1
mode of actionprotein synthesis | interferes
potency≥675 µg per mg
product lineBioReagent
Quality Level200
SMILES stringO[C@H]1[C@H](O)[C@@H](CO)O[C@H](O[C@@]2([H])[C@H](O[C@@]3([H])[C@H](O)[C@H](O[C@]4([H])[C@H](N)[C@@H](O)[C@H](O)[C@H](CN)O4)[C@@H](CO)O3)[C@@H](O)[C@H](N)C[C@@H]2N)[C@@H]1N.C
technique(s)cell culture | mammalian: suitable
Code
Description
Unit Size
List Price
Qty
P5057-1G
Unit:1G
List Price: £59.20
Source:List Price
ADD
Cas Number1263-89-4
This product has met the following criteria: